Articles
Network Meta-analysis of 1.5% Ruxolitinib Cream Versus Systemic Agents in the Treatment of Moderate Atopic Dermatitis
- Journal/Conference:
- Dermatology and Therapy
- Author(s):
- Melinda J. Gooderham, H. Chih-ho Hong, Di Wang, Becky Hooper, Avery Hughes-Martin, Heather Cameron, Laura Pastor, Alicia Pepper, Ping Wu, Ali Mojebi, Grace Wong, Rafael Marino, Marie-Lise Dion & Mehdi Larbi
- Publication Date:
- 2025
Cost-effectiveness Analysis of Biosimilar Denosumab for the Treatment of Women with Post-menopausal Osteoporosis in the United States: A Risk Based Analysis
- Journal/Conference:
- ACR
- Author(s):
- Li E, McTavish R, Mirzayeh Fashami F, Kane S, Schauf M
- Publication Date:
- 2025
Cost-effectiveness analysis of somapacitan-beco versus somatropin in the treatment of patients with pediatric growth hormone deficiency (GHD) in the United States
- Journal/Conference:
- AMCP Nexus
- Author(s):
- Tindal, M, Li, E, Mehl, A, Srivastava, A.
- Publication Date:
- 2025
Mission impossible? Caveats in interpreting and comparing long-term efficacy in biologic studies for moderate-to-severe plaque psoriasis
- Journal/Conference:
- JEADV
- Author(s):
- Langley RG, Egeberg A, Gooderham M, Bissonnette R, Ringuet J, Kalia S, Park-Wyllie L, Abbarin N, Tran D, Zara A, Yang YW, Strober B.
- Publication Date:
- 2025
- Condition:
- Psoriasis
A Matching-Adjusted Indirect Comparison of Guselkumab and Secukinumab in Patients with Psoriatic Arthritis Over 52 Weeks.
- Journal/Conference:
- Rheumatol Ther
- Author(s):
- Van Sanden S, Schubert A, Patel BP, Zimmermann M, Hassan F
- Publication Date:
- 2025
- Topic/Therapeutic Area:
- Psoriatic Arthritis
Identifying Challenges and Solutions for Indirect Comparisons in Myasthenia Gravis
- Journal/Conference:
- Journal of Comparative Effectiveness Research
- Author(s):
- Chris Drudge, Anna Nero, and Sumeet Singh
- Publication Date:
- 5 May 2025